MAS
TECH icon

Meeder Advisory Services’s Bio-Techne TECH Stock Holding History

Meeder Advisory Services’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
4,091
-816
-17% -$44.1K 0.01% 569
2026
Q1 		$256K Buy
4,907
+32
+0.7% +$1.92K 0.01% 572
2025
Q4 		$287K Buy
4,875
+587
+14% +$35.7K 0.01% 542
2025
Q3 		$239K Buy
4,288
+376
+10% +$20.1K 0.01% 546
2025
Q2 		$201K Buy
+3,912
New +$197K 0.01% 589
2023
Q3 		– Sell
-3,209
Closed -$262K – 438
2023
Q2 		$262K Buy
+3,209
New +$258K 0.03% 376

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meeder Advisory Services's TECH Position: Q2 2026 in Review

Meeder Advisory Services reduced its Bio-Techne (TECH) stake by 17% in Q2 2026, selling an estimated $44.1K and leaving 4,091 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #569.

Meeder Advisory Services first reported a position in TECH in Q2 2023 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Meeder Advisory Services held 4,091 shares of Bio-Techne worth $289K as of Q2 2026.
  • Meeder Advisory Services sold 816 Bio-Techne shares in Q2 2026, an estimated $44.1K.
  • Bio-Techne made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #569 holding.
  • Meeder Advisory Services first reported a position in Bio-Techne in Q2 2023 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.